BioAmber (BIOA) Tops Q3 EPS by 14c

BioAmber (NYSE: BIOA) reported Q3 EPS of ($0.27), $0.14 better than the analyst estimate of ($0.41). Revenue for the quarter came in at $300 thousand versus the consensus estimate of $2.3 million.

For earnings history and earnings-related data on BioAmber (BIOA) click here.

You May Also Be Interested In

• Barrick Mining said to delay IPO of American gold business to 2027
• Five Below (FIVE) Tops Q2 EPS by 35c, Beats on Revenue; Offers Q3 Revenue Guidance
• Tilly's, Inc. (TLYS) Tops Q2 EPS by 10c, Beats on Revenue